Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nanoviricides Inc (NY: NNVC )

1.450 +0.030 (+2.11%)
Streaming Delayed Price Updated: 9:30 AM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 156
Open 1.450
Bid (Size) 1.410 (6)
Ask (Size) 1.440 (1)
Prev. Close 1.420
Today's Range 1.450 - 1.450
52wk Range 1.040 - 3.880
Shares Outstanding 11,610,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Via ACCESSWIRE
NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET
Via ACCESSWIRE

Performance

YTD
+28.32%
+28.32%
1 Month
+5.07%
+5.07%
3 Month
-13.17%
-13.17%
6 Month
-58.57%
-58.57%
1 Year
-39.33%
-39.33%

More News

Read More
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027
Via FinancialNewsMedia
NanoViricides, Inc. Has Filed its Quarterly Report: Coronavirus Drug NV-CoV-2 IND Stage
Via ACCESSWIRE
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via TheNewswire.com
Topics Death
Exposures COVID-19 Death
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Via TheNewswire.com
Short Volatility Alert: NanoViricides, Inc.
Via Benzinga
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
Via InvestorPlace
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via News Direct
Topics Death
Exposures COVID-19 Death
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
Via Benzinga
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug NV-CoV-2 IND Stage
Via ACCESSWIRE
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
Via News Direct
Monkeypox Is Popping Up In Places It Shouldn't But NanoViricides Says It May Have A Solution
Via Benzinga
NanoViricides Provides Additional Details on Its Rapid Monkeypox Drug Strategy
Via ACCESSWIRE
NanoViricides Initiates New Drug Development To Combat Monkeypox Virus
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus
Via ACCESSWIRE
NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
30 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare
Via Benzinga
24 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
66 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.